NCT05062356View on ClinicalTrials.gov

Pain Control Following Total Hip Arthroplasty

PHASE1CompletedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

November 4, 2021

Primary Completion Date

August 15, 2024

Study Completion Date

August 15, 2024

Conditions
Chronic Postoperative Pain
Interventions
DRUG

Bupivacaine Hydrochloride 0.25% Injection Solution_#2

40cc

DRUG

EPINEPHrine 1:200,000 / Prilocaine HCl 4 % 1.8 ML Cartridge

10cc

DRUG

Bupivacaine Hydrochloride 0.5% Injection Solution_#2

20cc

DRUG

Ketorolac

15mg

Trial Locations (1)

H3T 1M5

St. Mary's Hospital Center, Montreal

All Listed Sponsors
lead

St. Mary's Research Center, Canada

OTHER

NCT05062356 - Pain Control Following Total Hip Arthroplasty | Biotech Hunter | Biotech Hunter